Acute allergic responses induce a prompt luminal entry of airway tissue eosinophils

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 4, 2003, Pages 439-448

  Erjefält, Jonas S ^a   Korsgren, Magnus ^b   Malm Erjefält, Monika ^b   Conroy, Dolores M ^b   Williams, Timothy J ^b   Persson, Carl G A ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BRADYKININ; CHEMOATTRACTANT; EOTAXIN; FORMOTEROL; PLASMA PROTEIN;

ACUTE PHASE RESPONSE; AIRWAY; ALLERGIC REACTION; ALLERGY TEST; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; EOSINOPHIL; EXTRAVASATION; GUINEA PIG; HYPOTHESIS; LEUKOCYTE MIGRATION; LUNG EXTRAVASCULAR FLUID; MALE; MIGRATION INHIBITION; NONHUMAN; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; TRACHEA MUCOSA;

ACUTE DISEASE; ANAPHYLAXIS; ANIMALS; ASTHMA; BRADYKININ; BRONCHI; BRONCHODILATOR AGENTS; CHEMOKINES, CC; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; EOSINOPHILS; ETHANOLAMINES; GUINEA PIGS; MALE; RESPIRATORY MUCOSA; RNA, MESSENGER;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 18344397638     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2003-0015OC     Document Type: Article

References (40)

1. Bochner, B. S., and L. M. Lichtenstein. 1991. Anaphylaxis. N. Engl. J. Med. 324:1785-1790.
2. O'Byrne, P. 1998. Asthma pathogenesis and allergen-induced late responses. J. Allergy Clin. Immunol. 102:S85-S89.
3. Rothenberg, M. E. Eosinophilia. 1998. N. Engl. J. Med. 338. 1592-1600.
4. Beasley, R., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
5. van Benten, I. J., A. Kleinjan, H. J. Neijens, A. D. Osterhaus, and W. J. Fokkens. 2001. Prolonged nasal eosinophilia in allergic patients after common cold. Allergy 56:949-956.
6. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1993. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am. Rev. Respir. Dis. 147:697-704.
7. Persson, C. G., J. S. Erjefält, L. Greiff, M. Andersson, I. Erjefält, R. W. Godfrey, M. Korsgren, M. Linden, F. Sundler, and C. Svensson. 1998. Plasma-derived proteins in airway defence, disease and repair of epithelial injury. Eur. Respir. J. 11:958-970.
8. Persson, C. G. A. 1997. Centennial notions of asthma as an eosinophilic, desquamative, exudative, and steroid-sensitive disease. Lancet 350:1021-1024.
9. McDonald, D. M. 1994. Endothelial gaps and permeability of venules in rat tracheas exposed to inflammatory stimuli. Am. J. Physiol. 266:L61-L83.
10. 2-macroglobulin. Immunol. Today 11:163-166.
11. Munoz, N. M., I. Douglas, D. Mayer, A. Herrnreiter, X. Zhu, and A. R. Leff. 1997. Eosinophil chemotaxis inhibited by 5-lipoxygenase blockade and leukotriene receptor antagonism. Am. J. Respir. Crit. Care Med. 155:1398-1403.
12. Erjefält, J. S., F. Sundler, and C. G. Persson. 1996. Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am. J. Respir. Crit. Care Med. 153:1666-1674.
13. Erjefält, J. S., M. Korsgren, M. C. Nilsson, F. Sundler, and C. G. Persson. 1997. Association between inflammation and epithelial damage-restitution processes in allergic airways in vivo. Clin. Exp. Allergy 27:1345-1357.
14. Greiff, L., H. Petersen, E. Mattsson, M. Andersson, J. S. Erjefält, M. Linden, C. Svensson, and C. G. Persson. 2001. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment. Clin. Exp. Allergy 31:1321-1327.
15. Lamkhioued, B., P. M. Renzi, Y. S. Abi, Z. E. Garcia, Z. Allakhverdi, O. Ghaffar, M. D. Rothenberg, A. D. Luster, and Q. Hamid. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J. Immunol. 159:4593-4601.
16. Cook, E. B., J. L. Stahl, C. M. Lilly, K. J. Haley, H. Sanchez, A. D. Luster, F. M. Graziano, and M. E. Rothenberg. 1998. Epithelial cells are a major cellular source of the chemokine eotaxin in the guinea pig lung. Allergy Asthma Proc. 19:15-22.
17. Humbles, A. A., D. M. Conroy, S. Marleau, S. M. Rankin, R. T. Palframan, A. E. Proudfoot, T. N. Wells, D. Li, P. K. Jeffery, D. A. Griffiths Johnson, T. J. Williams, and P. J. Jose. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
18. Erjefält, I., L. Greiff, U. Alkner, and C. G. Persson. 1993. Allergen-induced biphasic plasma exudation responses in guinea pig large airways. Am. Rev. Respir. Dis. 148:695-701.
19. Erjefält, I. A., Z. G. Wagner, S. E. Strand, and C. G. Persson. 1985. A method for studies of tracheobronchial microvascular permeability to macromolecules. J. Pharmacol. Methods 14:275-283.
20. Erjefält, I., and C. G. Persson. 1991. Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways. Am. Rev. Respir. Dis. 144:788-791.
21. Bolton, P. B., P. Lefevre, and D. M. McDonald, 1997. Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways. Am. J. Respir. Crit. Care Med. 155:1428-1435.
22. Jose, P. J., I. M. Adcock, D. A. Griffiths Johnson, N. Berkman, T. N. Wells, T. J. Williams, and C. A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. 205:788-794.
23. Gonzalo, J. A., C. M. Lloyd, L. Kremer, E. Finger, A. Martinez, M. H. Siegelman, M. Cybulsky, and J. C. Gutierrez-Ramos. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation: the role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98:2332-2345.
24. Haczku, A., R. Moqbel, M. Jacobson, A. B. Kay, P. J. Barnes, and K. F. Chung. 1995. T-cells subsets and activation in bronchial mucosa of sensitized Brown-Norway rats after single allergen exposure. Immunology 85:591-597.
25. Hutson, P. A., M. K. Church, T. P. Clay, P. Miller, and S. T. Holgate. 1988. Early and late-phase bronchoconstriction after allergen challenge of non anesthetized guinea pigs. I. The association of disordered airway physiology to leukocyte infiltration. Am. Rev. Respir. Dis. 137:548-557.
26. Hang, L., B. Frendeus, G. Godaly, and C. Svanborg. 2000. Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J. Infect. Dis. 182:1738-1748.
27. Criss, A. K., M. Silva, J. E. Casanova, and B. A. McCormick. 2001. Regulation of Salmonella-induced neutrophil transmigration by epithelial ADP-ribosylation factor 6. J. Biol. Chem. 276:48431-48439.
28. Berin, M. C., D. M. McKay, and M. H. Perdue. 1999. Immune-epithelial interactions in host defense. Am. J. Trop. Med. Hyg. 60:16-25.
29. Garcia, Z. E., M. E. Rothenberg, R. T. Ownbey, J. Celestin, P. Leder, and A. D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
30. Matthews, A. N., D. S. Friend, N. Zimmermann, M. N. Sarafi, A. D. Luster, E. Pearlman, S. E. Wert, and M. E. Rothenberg. 1998. Eotaxin is required for the baseline level of tissue eosinophils. Proc. Natl. Acad. Sci. USA 95:6273-6278.
31. Shi, H. Z., A. Humbles, C. Gerard, Z. Jin, and P. F. Weller. 2000. Lymph node trafficking and antigen presentation by endobronchial eosinophils. J. Clin. Invest. 105:945-953.
32. Weller, P. F., K. Lim, H. C. Wan, A. M. Dvorak, D. T. Wong, W. W. Cruikshank, H. Kornfeld, and D. M. Center. 1996. Role of the eosinophil in allergic reactions. Eur. Respir. J. Suppl. 22:109s-115s.
33. Erjefält, J. S., I. Erjefält, F. Sundler, and C. G. Persson. 1995. Epithelial pathways for luminal entry of bulk plasma. Clin. Exp. Allergy 25:187-195.
34. Greiff, L., P. Wollmer, M. Andersson, C. Svensson, and C. G. Persson. 1998. Effects of formoterol on histamine induced plasma exudation in induced sputum from normal subjects. Thorax 53:1010-1013.
35. Greiff, L., M. Andersson, J. S. Erjefält, C. Svensson, and C. G. Persson. 2002. Loss of size-selectivity at histamine-induced exudation of plasma proteins in atopic nasal airways. Clin. Physiol. Funct. Imaging 22:28-31.
36. Collins, P. D., S. Marleau, D. A. Griffiths Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
37. Li, D., D. Wang, J. D. Griffiths, T. N. Wells, T. J. Williams, P. J. Jose, and P. K. Jeffery. 1997. Eotaxin protein and gene expression in guinea-pig lungs: constitutive expression and upregulation after allergen challenge. Eur. Respir. J. 10:1946-1954.
38. Humbles, A. A., B. Lu, D. S. Friend, S. Okinaga, J. Lora, A. Al Garawi, T. R. Martin, N. P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA 99:1479-1484.
39. Hanazawa, T., J. D. Antuni, S. A. Kharitonov, and P. J. Barnes. 2000. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 105:58-64.
40. Fukuyama, S., H. Inoue, H. Aizawa, M. Oike, M. Kitaura, O. Yoshie, and N. Hara. 2000. Effect of eotaxin and platelet-activating factor on airway inflammation and hyperresponsiveness in guinea pigs in vivo. Am. J. Respir. Crit. Care Med. 161:1844-1849.